120 related articles for article (PubMed ID: 12925571)
1. Fly models of Huntington's disease.
Marsh JL; Pallos J; Thompson LM
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R187-93. PubMed ID: 12925571
[TBL] [Abstract][Full Text] [Related]
2. Animal models of Huntington's disease.
Gárdián G
Ideggyogy Sz; 2006 Nov; 59(11-12):396-9. PubMed ID: 17203874
[TBL] [Abstract][Full Text] [Related]
3. [Experimental models of Huntington's disease].
García-Ramos R; del Val-Fernández J; Catalán-Alonso MJ; Barcia-Albacar JA; Matías-Guiu J
Rev Neurol; 2007 Oct 1-15; 45(7):437-41. PubMed ID: 17918112
[TBL] [Abstract][Full Text] [Related]
4. Huntington's disease - new perspectives based on neuroendocrine changes in rodent models.
Petersén A; Hult S; Kirik D
Neurodegener Dis; 2009; 6(4):154-64. PubMed ID: 19521064
[TBL] [Abstract][Full Text] [Related]
5. [Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
Kanazawa I
Jikken Dobutsu; 1990 Apr; 39(2):168-72. PubMed ID: 2141819
[No Abstract] [Full Text] [Related]
6. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
Browne SE
Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
[TBL] [Abstract][Full Text] [Related]
7. Strenuous, intensive, long-term exercise does not prevent or delay the onset of Huntington's disease.
Altschuler EL
Med Hypotheses; 2006; 67(6):1429-30. PubMed ID: 16824703
[TBL] [Abstract][Full Text] [Related]
8. Huntington's disease: modeling the gait disorder and proposing novel treatments.
Banaie M; Sarbaz Y; Gharibzadeh S; Towhidkhah F
J Theor Biol; 2008 Sep; 254(2):361-7. PubMed ID: 18621402
[TBL] [Abstract][Full Text] [Related]
9. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
Gil JM; Rego AC
Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572
[TBL] [Abstract][Full Text] [Related]
10. Emerging drug therapies in Huntington's disease.
Mason SL; Barker RA
Expert Opin Emerg Drugs; 2009 Jun; 14(2):273-97. PubMed ID: 19453283
[TBL] [Abstract][Full Text] [Related]
11. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.
Fan MM; Raymond LA
Prog Neurobiol; 2007 Apr; 81(5-6):272-93. PubMed ID: 17188796
[TBL] [Abstract][Full Text] [Related]
13. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
Glynn D; Reim K; Brose N; Morton AJ
Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
[TBL] [Abstract][Full Text] [Related]
14. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
15. Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease.
Popoli P; Blum D; Martire A; Ledent C; Ceruti S; Abbracchio MP
Prog Neurobiol; 2007 Apr; 81(5-6):331-48. PubMed ID: 17303312
[TBL] [Abstract][Full Text] [Related]
16. Citicoline is not protective in experimental models of Huntington's disease.
Mievis S; Levivier M; Vassart G; Brotchi J; Ledent C; Blum D
Neurobiol Aging; 2007 Dec; 28(12):1944-6. PubMed ID: 17064815
[TBL] [Abstract][Full Text] [Related]
17. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
18. Animal welfare and the refinement of neuroscience research methods--a case study of Huntington's disease models.
Olsson IA; Hansen AK; Sandøe P
Lab Anim; 2008 Jul; 42(3):277-83. PubMed ID: 18625582
[TBL] [Abstract][Full Text] [Related]
19. Gene expression in Huntington's disease skeletal muscle: a potential biomarker.
Strand AD; Aragaki AK; Shaw D; Bird T; Holton J; Turner C; Tapscott SJ; Tabrizi SJ; Schapira AH; Kooperberg C; Olson JM
Hum Mol Genet; 2005 Jul; 14(13):1863-76. PubMed ID: 15888475
[TBL] [Abstract][Full Text] [Related]
20. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
Wade A; Jacobs P; Morton AJ
Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
